Русский

Pharmaceutical Industry Information Portal

HomeNews

News

Regulatory News

WHO revises guidance on GMPs for investigational products and R&D facilities

Techno -
WHO said the objective of the update is to align the guidance with “current expectations and trends in good manufacturing practices”.
Manufacturers News

Russian ministers visit Pharmasintez production site

Techno -
In 2020 the share of the Pharmasyntez Group of Companies in the hospital procurements segment reached 7.3% in terms of volume.
World Pharma News

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Techno -
Following closing of the acquisition, Bayer will own full rights to Vividion’s proprietary discovery platform, which comprises three integrated, synergistic components.
Manufacturers News

Petrovax to manufacture up to 10 mln doses of China’s Convidencia a month

Techno -
The company said earlier that it planned to commission its Convidencia full cycle production line by the end of 2021.
Discovery and Development

Combination of the Sputnik Light with others vaccines demonstrates high safety profile

Techno -
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.
World Pharma News

EC approves contract for a potential COVID-19 vaccine with Novavax

Techno -
Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses.
1...848586...111Page 85 of 111
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories